143 related articles for article (PubMed ID: 30476019)
1. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
[TBL] [Abstract][Full Text] [Related]
2. Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice.
Islam S; Yoshioka K; Aki S; Ishimaru K; Yamada H; Takuwa N; Takuwa Y
J Physiol Sci; 2020 Mar; 70(1):18. PubMed ID: 32192434
[TBL] [Abstract][Full Text] [Related]
3. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.
Wang Y; Yoshioka K; Azam MA; Takuwa N; Sakurada S; Kayaba Y; Sugimoto N; Inoki I; Kimura T; Kuwaki T; Takuwa Y
Biochem J; 2006 Mar; 394(Pt 3):581-92. PubMed ID: 16336212
[TBL] [Abstract][Full Text] [Related]
4. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats.
Seok YM; Azam MA; Okamoto Y; Sato A; Yoshioka K; Maeda M; Kim I; Takuwa Y
Hypertension; 2010 Nov; 56(5):934-41. PubMed ID: 20921425
[TBL] [Abstract][Full Text] [Related]
6. The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.
Aung KT; Yoshioka K; Aki S; Ishimaru K; Takuwa N; Takuwa Y
J Physiol Sci; 2019 Mar; 69(2):263-280. PubMed ID: 30374841
[TBL] [Abstract][Full Text] [Related]
7. Sevoflurane and isoflurane inhibit KCl-induced Class II phosphoinositide 3-kinase α subunit mediated vasoconstriction in rat aorta.
Yang S; Wu Q; Huang S; Wang Z; Qi F
BMC Anesthesiol; 2016 Aug; 16(1):63. PubMed ID: 27538808
[TBL] [Abstract][Full Text] [Related]
8. The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation.
Harada K; Truong AB; Cai T; Khavari PA
Mol Cell Biol; 2005 Dec; 25(24):11122-30. PubMed ID: 16314532
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ; Maffucci T
Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
[TBL] [Abstract][Full Text] [Related]
10. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle.
Azam MA; Yoshioka K; Ohkura S; Takuwa N; Sugimoto N; Sato K; Takuwa Y
J Pharmacol Exp Ther; 2007 Feb; 320(2):907-16. PubMed ID: 17110524
[TBL] [Abstract][Full Text] [Related]
11. Essential role of class II phosphatidylinositol-3-kinase-C2α in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells.
Biswas K; Yoshioka K; Asanuma K; Okamoto Y; Takuwa N; Sasaki T; Takuwa Y
J Biol Chem; 2013 Jan; 288(4):2325-39. PubMed ID: 23192342
[TBL] [Abstract][Full Text] [Related]
12. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
13. RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction.
Tahara M; Morishige K; Sawada K; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Endocrinology; 2002 Mar; 143(3):920-9. PubMed ID: 11861513
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity.
Alliouachene S; Bilanges B; Chicanne G; Anderson KE; Pearce W; Ali K; Valet C; Posor Y; Low PC; Chaussade C; Scudamore CL; Salamon RS; Backer JM; Stephens L; Hawkins PT; Payrastre B; Vanhaesebroeck B
Cell Rep; 2015 Dec; 13(9):1881-94. PubMed ID: 26655903
[TBL] [Abstract][Full Text] [Related]
15. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
Mavrommati I; Cisse O; Falasca M; Maffucci T
Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
Alliouachene S; Bilanges B; Chaussade C; Pearce W; Foukas LC; Scudamore CL; Moniz LS; Vanhaesebroeck B
Diabetologia; 2016 Jul; 59(7):1503-1512. PubMed ID: 27138914
[TBL] [Abstract][Full Text] [Related]
17. Class II PI3K Functions in Cell Biology and Disease.
Gulluni F; De Santis MC; Margaria JP; Martini M; Hirsch E
Trends Cell Biol; 2019 Apr; 29(4):339-359. PubMed ID: 30691999
[TBL] [Abstract][Full Text] [Related]
18. Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.
Yoshioka K; Yoshida K; Cui H; Wakayama T; Takuwa N; Okamoto Y; Du W; Qi X; Asanuma K; Sugihara K; Aki S; Miyazawa H; Biswas K; Nagakura C; Ueno M; Iseki S; Schwartz RJ; Okamoto H; Sasaki T; Matsui O; Asano M; Adams RH; Takakura N; Takuwa Y
Nat Med; 2012 Oct; 18(10):1560-9. PubMed ID: 22983395
[TBL] [Abstract][Full Text] [Related]
19. Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Chikh A; Ferro R; Abbott JJ; Piñeiro R; Buus R; Iezzi M; Ricci F; Bergamaschi D; Ostano P; Chiorino G; Lattanzio R; Broggini M; Piantelli M; Maffucci T; Falasca M
Oncotarget; 2016 Apr; 7(14):18325-45. PubMed ID: 26934321
[TBL] [Abstract][Full Text] [Related]
20. PI3K-C2β limits mTORC1 signaling and angiogenic growth.
Kobialka P; Llena J; Deleyto-Seldas N; Munar-Gelabert M; Dengra JA; Villacampa P; Albinyà-Pedrós A; Muixi L; Andrade J; van Splunder H; Angulo-Urarte A; Potente M; Grego-Bessa J; Castillo SD; Vanhaesebroeck B; Efeyan A; Graupera M
Sci Signal; 2023 Nov; 16(813):eadg1913. PubMed ID: 38015911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
